Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asenapine for Bipolar Depression

NCT01807741 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01807741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asenapine for Bipolar Depression
Lead sponsor
University of Cincinnati
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2013
Completion date
July 31, 2017
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression